Literature DB >> 22706009

The history of antiretroviral therapy and of its implementation in resource-limited areas of the world.

Stefano Vella1, Bernard Schwartländer, Salif Papa Sow, Serge Paul Eholie, Robert L Murphy.   

Abstract

HIV/AIDS not only represents the most severe epidemic in modern times, but also the greatest public health challenge in history. The response of the scientific community has been impressive and in just a few years, turned an inevitably fatal disease into a chronic manageable although not yet curable condition. The development of antiretroviral therapy is not only the history of scientific advancements: it is the result of the passionate 'alliance' towards a common goal between researchers, doctors and nurses, pharmaceutical industries, regulators, public health officials and the community of HIV-infected patients, which is rather unique in the history of medicine. In addition, the rapid and progressive development of antiretroviral therapy has not only proven to be life-saving for many millions but has been instrumental in unveiling the inequities in access to health between rich and poor countries of the world. Optimal benefits indeed, are not accessible to all people living with HIV, with challenges to coverage and sustainability in low and middle income countries. This paper will review the progress made, starting from the initial despairing times, till the current battle towards universal access to treatment and care for all people living with HIV.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22706009     DOI: 10.1097/QAD.0b013e32835521a3

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  52 in total

Review 1.  Coronary Artery Disease in HIV-Infected Patients: Downside of Living Longer.

Authors:  John Charles A Lacson; Revery P Barnes; Hossein Bahrami
Journal:  Curr Atheroscler Rep       Date:  2017-04       Impact factor: 5.113

Review 2.  Risk perception and communication in sub-Saharan Africa.

Authors:  Alexander Dodoo; Bruce Hugman
Journal:  Drug Saf       Date:  2012-11-01       Impact factor: 5.606

Review 3.  Beyond one pill, once daily: current challenges of antiretroviral therapy management in the United States.

Authors:  Mary Clare Masters; Karen M Krueger; Janna L Williams; Lindsay Morrison; Susan E Cohn
Journal:  Expert Rev Clin Pharmacol       Date:  2019-12       Impact factor: 5.045

4.  Critical considerations for adopting the HIV 'treat all' approach in Zimbabwe: is the nation poised?

Authors:  K C Takarinda; A D Harries; T Mutasa-Apollo
Journal:  Public Health Action       Date:  2016-02-11

Review 5.  Structure, function, and inhibitor targeting of HIV-1 Nef-effector kinase complexes.

Authors:  Ryan P Staudt; John J Alvarado; Lori A Emert-Sedlak; Haibin Shi; Sherry T Shu; Thomas E Wales; John R Engen; Thomas E Smithgall
Journal:  J Biol Chem       Date:  2020-08-29       Impact factor: 5.157

6.  RON receptor tyrosine kinase, a negative regulator of inflammation, is decreased during simian immunodeficiency virus-associated central nervous system disease.

Authors:  Daniele C Cary; Janice E Clements; Andrew J Henderson
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

Review 7.  Housing status and the health of people living with HIV/AIDS.

Authors:  M-J Milloy; Brandon D L Marshall; Julio Montaner; Evan Wood
Journal:  Curr HIV/AIDS Rep       Date:  2012-12       Impact factor: 5.071

8.  Temporal trends in the discontinuation of first-line antiretroviral therapy.

Authors:  Alejandro Gonzalez-Serna; Keith Chan; Benita Yip; William Chau; Rachel McGovern; Hasina Samji; Viviane Dias Lima; Robert S Hogg; Richard Harrigan
Journal:  J Antimicrob Chemother       Date:  2014-04-15       Impact factor: 5.790

9.  Social Support Mitigates Negative Impact of Food Insecurity on Antiretroviral Adherence Among Postpartum Women in Western Kenya.

Authors:  Mira Wang; Joshua D Miller; Shalean M Collins; Marianne V Santoso; Pauline Wekesa; Hideaki Okochi; Maricianah Onono; Sheri Weiser; Monica Gandhi; Sera L Young
Journal:  AIDS Behav       Date:  2020-10

Review 10.  Beneficial and Adverse Effects of cART Affect Neurocognitive Function in HIV-1 Infection: Balancing Viral Suppression against Neuronal Stress and Injury.

Authors:  Nina Y Yuan; Marcus Kaul
Journal:  J Neuroimmune Pharmacol       Date:  2019-08-06       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.